Michael Vasconcelles - Aug 15, 2022 Form 4 Insider Report for Magenta Therapeutics, Inc. (MGTA)

Role
Director
Signature
/s/ Cindy Driscoll, Attorney-in-Fact for Michael Vasconcelles
Stock symbol
MGTA
Transactions as of
Aug 15, 2022
Transactions value $
$0
Form type
4
Date filed
8/17/2022, 08:19 AM
Next filing
Jan 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGTA Stock Option (Right to Buy) Award $0 +40K $0.00 40K Aug 15, 2022 Common Stock 40K $1.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable over three years, with 33% of this option vesting on August 15, 2023, and the remainder vesting in 24 equal monthly installments thereafter.